ClinicalTrials.govpublic full text
Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis
lymphoma, large b-cell, diffuse, dlbcl, chemoimmunotherapy, high risk, cns prophylaxis, biomarker-driven, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800957
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.